Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.
Huuhtanen J, Kasanen H, Peltola K, Lönnberg T, Glumoff V, Brück O, Dufva O, Peltonen K, Vikkula J, Jokinen E, Ilander M, Lee MH, Mäkelä S, Nyakas M, Li B, Hernberg M, Bono P, Lähdesmäki H, Kreutzman A, Mustjoki S.
Huuhtanen J, et al. Among authors: bono p.
J Clin Invest. 2023 Mar 15;133(6):e164809. doi: 10.1172/JCI164809.
J Clin Invest. 2023.
PMID: 36719749
Free PMC article.